AnaMar AB

AnaMar AB is an established and well financed Swedish biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic strategies to treat inflammation, pain and fibrosis.

The Company has developed a unique technology platform, based on the knowledge that a subset of peripheral serotonin receptors plays an important role in the regulation of inflammation, pain and fibrosis. AnaMar scientists have developed new promising drug candidates from several chemical classes that target these receptors, showing potent anti-inflammatory, analgesic and anti-fibrotic effects.

Kategorier: Biotech

Gå till AnaMar ABs hemsida